Inventor · disambiguated record
Kai Donsbach
Also filed as: DONSBACH KAI · DONSBACH KAI OLIVER
5 granted patents·7 pending applications·80 citations·filing 2002–2021
78Inventor score
Top patents by PatentIndex Score
12 records- 0193US7449591B2Process of removing transition metalsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Nov 11, 2008·28 cites·19 claims
- 0285US7148347B2Process for preparing macrocyclic compoundsBOEHRINGER INGELHEIM INT·Filed 2004·Granted Dec 12, 2006·35 cites·22 claims
- 0382US6737432B2Crystalline form of telmisartan sodiumBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted May 18, 2004·17 cites·9 claims
- 0454US2023159452A1Regioselective oxidation of heterocyclic alpha-amino amidesPHARMAZELL GMBH·Filed 2021·Application pending·0 cites
- 0553US12305212B2Method for the hydroxylation of steroidsPHARMAZELL GMBH·Filed 2021·Granted May 20, 2025·0 cites·10 claims
- 0653US2006276526A1Crystalline Form of Telmisartan SodiumBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 0753US2023183177A1Enantioselective chemo-enzymatic synthesis of optically active amino amide compoundsPHARMAZELL GMBH·Filed 2021·Application pending·0 cites
- 0850US2023053763A1Method for preparing periodatesPHARMAZELL GMBH·Filed 2020·Application pending·0 cites
- 0945US2004162327A1Crystalline form of telmisartan sodiumBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 1043US7282583B2Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-oneBOEHRINGER INGELHEIM INT·Filed 2006·Granted Oct 16, 2007·0 cites·16 claims
- 1140US2021108245A1Enantioselective Biocatalytic Preparation of 4-Cyano-Substituted 1-Aminoindane and OzanimodPHARMAZELL GMBH·Filed 2019·Application pending·0 cites
- 1240US2021340115A1A PROCESS FOR THE PREPARATION OF OZANIMOD AND ITS INTERMEDIATE (S)-l-AMINO-2,3-DIHYDRO-1H-INDENE-4-CARBONITRILEPHARMAZELL GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kai Donsbach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →